102
Participants
Start Date
June 12, 2015
Primary Completion Date
September 16, 2016
Study Completion Date
August 17, 2018
Subjects do not receive study medication in this study 202094
Participants do not receive study medication in this study 202094.
GSK Investigational Site, Brussels
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Rosario
GSK Investigational Site, Liège
GSK Investigational Site, Ghent
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Lynchburg
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Málaga
GSK Investigational Site, Murcia
GSK Investigational Site, Cartagena (Murcia)
GSK Investigational Site, West Palm Beach
GSK Investigational Site, Seville
GSK Investigational Site, St Louis
GSK Investigational Site, Omaha
GSK Investigational Site, Los Angeles
GSK Investigational Site, San Francisco
GSK Investigational Site, Ciudad Autonoma de Buenos Aires
GSK Investigational Site, Ciudad de Buenos Aires
GSK Investigational Site, Vancouver
GSK Investigational Site, Toronto
GSK Investigational Site, Montreal
GSK Investigational Site, Québec
GSK Investigational Site, Alicante
GSK Investigational Site, Badalona
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Palma de Mallorca
GSK Investigational Site, London
GSK Investigational Site, London
Lead Sponsor
Collaborators (2)
Janssen Pharmaceuticals
INDUSTRY
GlaxoSmithKline
INDUSTRY
ViiV Healthcare
INDUSTRY